Emily M. Eshleman
- Co-authors
- Theresa AlenghatVivienne WooLaurel LenzLaura EnglemanJordan WhittSeika Hashimoto‐HillDavid HaslamShu-en Wu
- Topics
- Gut microbiota and health (8 papers)IL-33, ST2, and ILC Pathways (6 papers)Immune Cell Function and Interaction (6 papers)
- Partner nations
- United StatesCanadaAustria
In The Last Decade
Emily M. Eshleman
21 papers receiving 619 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Biology 314
- Immunology 173
- Physiology 101
- Epidemiology 100
- Oncology 69
Countries citing papers authored by Emily M. Eshleman
This map shows the geographic impact of Emily M. Eshleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily M. Eshleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily M. Eshleman more than expected).
Fields of papers citing papers by Emily M. Eshleman
This network shows the impact of papers produced by Emily M. Eshleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily M. Eshleman. The network helps show where Emily M. Eshleman may publish in the future.
Co-authorship network of co-authors of Emily M. Eshleman
This figure shows the co-authorship network connecting the top 25 collaborators of Emily M. Eshleman. A scholar is included among the top collaborators of Emily M. Eshleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily M. Eshleman. Emily M. Eshleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 14 | |
| 3 | Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunitybreakdown → | 63 |
| 4 | 34 | |
| 5 | 13 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 77 | |
| 10 | 14 | |
| 11 | 66 | |
| 12 | 164 | |
| 13 | 3 | |
| 14 | 1 | |
| 15 | 19 | |
| 16 | 4 | |
| 17 | 21 | |
| 18 | 34 | |
| 19 | 39 | |
| 20 | 40 |
About Emily M. Eshleman
Emily M. Eshleman is a scholar working on Immunology, Emergency Medical Services and Dermatology, having authored 21 papers that have together received 626 indexed citations. Recurring topics across this work include Gut microbiota and health (8 papers), IL-33, ST2, and ILC Pathways (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Biological Psychiatry (22 citations), Immunology (173 citations) and Molecular Biology (314 citations). Emily M. Eshleman has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Theresa Alenghat, Vivienne Woo, Laurel Lenz, Laura Engleman, Jordan Whitt, Seika Hashimoto‐Hill, David Haslam, Shu-en Wu, Rebekah Karns and Lee A. Denson. Their work appears in journals such as Nature, Cell and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.